T2 Biosystems, Inc. (NASDAQ:TTOO – Get Free Report) shares crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $0.01 and traded as low as $0.0025. T2 Biosystems shares last traded at $0.0025, with a volume of 26,090 shares.
T2 Biosystems Stock Down 50.0%
The business has a fifty day simple moving average of $0.01 and a two-hundred day simple moving average of $0.03. The company has a market cap of $52,607.50, a P/E ratio of 0.00 and a beta of 0.74.
T2 Biosystems Company Profile
T2 Biosystems, Inc is a commercial‐stage diagnostics company focused on developing and marketing innovative, rapid diagnostic products designed to improve patient outcomes and reduce healthcare costs. The company’s proprietary T2 Magnetic Resonance (T2MR) technology enables direct detection of pathogens and biomarkers in whole blood without the need for culture, delivering results in hours rather than days. T2 Biosystems’ core mission is to provide clinicians with faster, actionable data to guide treatment decisions, particularly in the management of sepsis, bloodstream infections and other life‐threatening conditions.
The flagship product, the T2Dx® Instrument, serves as the platform for all T2 assays.
See Also
- Five stocks we like better than T2 Biosystems
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- Punch these codes into your ordinary brokerage account
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
